Loading…
Lydia Co. Ltd. was cited for failing to properly register and list eight drug products, including topical analgesics and cold remedies, in violation of Section 510(j)(1) of the FD&C Act and 21 CFR Part 207. The company submitted contradictory information between product labeling and electronic listing files, with discrepancies including mismatched active ingredient declarations between the two submissions. This violation followed a March 17, 2023 deficiency letter and resulted in a May 1, 2023 data removal action that delisted the products from FDA's Online NDC Directory.